Sign in now to see personalised content appear here.
You can also see your reading history and subscription details on your subscriber page.
Single-step fermentative method for the production of pravastatin will facilitate industrial-scale manufacture
Investment has been implemented in response to increased customer demand for speciality handling
Thousands of EU pharma manufacturers and packers face the costly prospect of re-engineering their production lines to satisfy the Falsified Medicines Directive. Offline systems could be one way of easing the burden, says Richard Pether, Director, Rotech
Work on he new building is expected to be completed by 2017
Sumitomo Demag ejector and mould control algorithm synchronises ejector forward speed with mould open speed
One barrier to implementing product serialisation has been the variation and uncertainty of what would be required in the various regions around the world. Susan Birks talked to key players about how ready the industry is to meet the deadlines
They say the claim could bias research funding and health policy decisions
Implementation of the EU Falsified Medicines Directive requires various equipment and systems to be in place by 2018. Harry Thomason, MD, Travtec Group looks at systems with true vision that will help manufacturers with compliance
But high biobetter prices could facilitate the adoption of GH biosimilars
Fragment-based drug discovery is providing more efficient ways to identify and advance true drug leads. Dr Paul Belcher, Development Leader, Biacore, GE Healthcare looks at recent developments and the benefits of surface plasmon resonance
Invests in additional modules for its COBAS 6000 analysis system
The UK has historically had a strong tradition in pharmaceutical production. James Christie, ABPI Project Director for Manufacturing, looks at initiatives aimed at strengthening the UK’s position in the fast-changing global manufacturing sector